Patents by Inventor Ian Frank

Ian Frank has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF AN ULTRA-WIDEBAND (UWB) RADIO IN PLAYBACK DEVICES
    Publication number: 20250044397
    Abstract: Embodiments disclosed herein include playback devices with multiple antennas and antenna switching capabilities employed to determine relative locations of other playback devices based on ultra-wideband (UWB) signals transmitted between the devices. In some embodiments, the determination is based on an estimation of angle of arrival of UWB signals received from another playback device. In some embodiments, the determination is based on an estimation of range between antennas of the devices, for example derived from time of flight measurements of the UWB signals received from another playback device. In some embodiments, trilateration techniques are used to determine the relative locations from the estimated ranges. The relative locations are used to assist with installation and setup of the devices in a given environment. After determination of the relative locations, a playback configuration mode can be set for the playback devices to include playback of one or more channels of multi-channel audio content.
    Type: Application
    Filed: September 29, 2022
    Publication date: February 6, 2025
    Inventors: Kasra PAYANDEHJOO, Nobuo NAKATA, Ian FRANK
  • Restimulation of cryopreserved tumor infiltrating lymphocytes
    Patent number: 12188048
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Grant
    Filed: August 15, 2022
    Date of Patent: January 7, 2025
    Assignee: IOVANCE BIOTHERAPEUTICS, INC.
    Inventors: Ian Frank, Michael T. Lotze
  • Restimulation of cryopreserved tumor infiltrating lymphocytes
    Patent number: 11975028
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Grant
    Filed: August 11, 2022
    Date of Patent: May 7, 2024
    Assignee: IOVANCE BIOTHERAPEUTICS, INC.
    Inventors: Ian Frank, Michael T. Lotze
  • Restimulation of cryopreserved tumor infiltrating lymphocytes
    Patent number: 11969444
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Grant
    Filed: August 11, 2022
    Date of Patent: April 30, 2024
    Assignee: IOVANCE BIOTHERAPEUTICS, INC.
    Inventors: Ian Frank, Michael T. Lotze
  • Restimulation of cryopreserved tumor infiltrating lymphocytes
    Patent number: 11865140
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after restimulation.
    Type: Grant
    Filed: August 15, 2022
    Date of Patent: January 9, 2024
    Assignee: Iovance Biotherapeutics, Inc.
    Inventors: Ian Frank, Michael T. Lotze
  • Restimulation of cryopreserved tumor infiltrating lymphocytes
    Patent number: 11857573
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Grant
    Filed: August 11, 2022
    Date of Patent: January 2, 2024
    Assignee: Iovance Biotherapeutics, Inc.
    Inventors: Ian Frank, Michael T. Lotze
  • RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
    Publication number: 20230030883
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Application
    Filed: August 15, 2022
    Publication date: February 2, 2023
    Inventors: Ian Frank, Michael T. Lotze
  • RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
    Publication number: 20220395534
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Application
    Filed: August 15, 2022
    Publication date: December 15, 2022
    Inventors: Ian Frank, Michael T. Lotze
  • RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
    Publication number: 20220387500
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Application
    Filed: August 11, 2022
    Publication date: December 8, 2022
    Inventors: Ian Frank, Michael T. Lotze
  • RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
    Publication number: 20220387501
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Application
    Filed: August 11, 2022
    Publication date: December 8, 2022
    Inventors: Ian Frank, Michael T. Lotze
  • RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
    Publication number: 20220378837
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Application
    Filed: May 31, 2022
    Publication date: December 1, 2022
    Inventors: Ian Frank, Michael T. Lotze
  • RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
    Publication number: 20220378834
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Application
    Filed: August 11, 2022
    Publication date: December 1, 2022
    Inventors: Ian Frank, Michael T. Lotze
  • Restimulation of cryopreserved tumor infiltrating lymphocytes
    Patent number: 11369637
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Grant
    Filed: December 11, 2021
    Date of Patent: June 28, 2022
    Assignee: Iovance Biotherapeutics, Inc.
    Inventors: Ian Frank, Michael T. Lotze
  • Restimulation of cryopreserved tumor infiltrating lymphocytes
    Patent number: 11364266
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Grant
    Filed: December 11, 2021
    Date of Patent: June 21, 2022
    Assignee: Iovance Biotherapeutics, Inc.
    Inventors: Ian Frank, Michael T. Lotze
  • Restimulation of cryopreserved tumor infiltrating lymphocytes
    Patent number: 11351197
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Grant
    Filed: September 21, 2021
    Date of Patent: June 7, 2022
    Assignee: Iovante Biotherapeutics, Inc.
    Inventors: Ian Frank, Michael T. Lotze
  • Restimulation of cryopreserved tumor infiltrating lymphocytes
    Patent number: 11351198
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Grant
    Filed: September 21, 2021
    Date of Patent: June 7, 2022
    Assignee: Iovance Biotherapeutics, Inc.
    Inventors: Ian Frank, Michael T. Lotze
  • Restimulation of cryopreserved tumor infiltrating lymphocytes
    Patent number: 11351199
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Grant
    Filed: December 9, 2021
    Date of Patent: June 7, 2022
    Assignee: Iovance Biotherapeutics, Inc.
    Inventors: Ian Frank, Michael T. Lotze
  • Restimulation of cryopreserved tumor infiltrating lymphocytes
    Patent number: 11344580
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Grant
    Filed: September 21, 2021
    Date of Patent: May 31, 2022
    Assignee: Iovance Biotherapeutics, Inc.
    Inventors: Ian Frank, Michael T. Lotze
  • Restimulation of cryopreserved tumor infiltrating lymphocytes
    Patent number: 11344581
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Grant
    Filed: December 9, 2021
    Date of Patent: May 31, 2022
    Assignee: Iovance Biotherapeutics, Inc.
    Inventors: Ian Frank, Michael T. Lotze
  • RESTIMULATION OF CRYOPRESERVED TUMOR INFILTRATING LYMPHOCYTES
    Publication number: 20220133798
    Abstract: The present disclosure provides methods for re-stimulating TIL populations that lead to improved phenotype and increased metabolic health of the TILs and provides methods of assaying for TIL populations to determine suitability for more efficacious infusion after re-stimulation.
    Type: Application
    Filed: December 11, 2021
    Publication date: May 5, 2022
    Inventors: Ian Frank, Michael T. Lotze